Brain metastases (cerebral metastases; secondary brain tumours, metastatic CNS disease)
Oncology / neuro-oncology emergency · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Commonest intracranial tumours in adults (lung, breast, melanoma, renal, colorectal primaries). Present with headache, focal deficit, seizures, or raised intracranial pressure; may be first presentation of cancer. ED priorities: manage raised ICP and seizures, give corticosteroids for symptomatic oedema, image, and refer to neuro-oncology/oncology.
Red flags
- Reduced GCS / impending herniation (fixed dilated pupil, Cushing response)
- Status epilepticus
- Acute haemorrhage into metastasis
- Obstructive hydrocephalus (posterior fossa lesion)
- Rapidly progressive focal deficit
Assessment
Differential diagnosis
- Primary brain tumour (glioma, meningioma)
- Brain abscess / cerebral toxoplasmosis (immunocompromised)
- Haemorrhage / ischaemic stroke
- Demyelination, PRES
- Paraneoplastic / leptomeningeal disease
Investigations
- CT head (urgent) - lesions with vasogenic oedema; CT with contrast improves detection
- MRI brain with contrast = investigation of choice (number, location, leptomeningeal involvement)
- FBC, U&E, calcium, glucose, coagulation (haemorrhagic mets - melanoma, renal, choriocarcinoma, thyroid)
- CT chest/abdomen/pelvis +/- PET to find primary if unknown
- Avoid LP if raised ICP/mass effect until imaging clears it
Management
- Assess and manage raised ICP / impending herniation (head up 30 degrees, airway, avoid hypotension/hypoxia)
- Corticosteroids (dexamethasone) for symptomatic vasogenic oedema - add PPI gastroprotection; avoid steroids pre-biopsy if CNS lymphoma suspected (discuss first)
- Treat seizures with benzodiazepine then antiepileptic; do NOT give routine prophylactic antiepileptics if no seizure
- Urgent neurosurgical referral for solitary/accessible lesion, significant mass effect, hydrocephalus or diagnostic uncertainty
- Discuss with oncology/neuro-oncology: options include surgery, stereotactic radiosurgery, whole-brain radiotherapy, systemic therapy (some targeted agents/immunotherapy cross blood-brain barrier)
- Find the primary if unknown (staging CT/PET, tissue for molecular markers)
- Address VTE risk (high) - anticoagulation possible in most brain mets but weigh haemorrhagic lesions; palliative care involvement where appropriate
Drugs & doses
Dexamethasone 8-16 mg IV/PO loading then 4 mg every 6 h (reduce to lowest effective dose; add PPI) [verify local dose]
Lorazepam 4 mg IV (or diazepam 10 mg IV/PR) for acute seizure [verify local dose]
Levetiracetam 500-1000 mg IV/PO twice daily (or per status epilepticus protocol) for seizure control [verify local dose]
Hypertonic saline or mannitol 0.5-1 g/kg IV for impending herniation (neurosurgical liaison) [verify local dose]
Proton pump inhibitor cover with corticosteroids
Analgesia for headache (avoid oversedation masking deterioration)
Disposition
Admit under medicine/oncology; neurosurgery if mass effect/hydrocephalus/solitary lesion. Reduced GCS/seizures/herniation -> resus/HDU. MDT (neuro-oncology) planning.
Complications & pitfalls
- Cerebral herniation / death
- Intratumoural haemorrhage
- Obstructive hydrocephalus
- Seizures / status epilepticus
- Steroid toxicity, VTE
Exam pearls
- Do not give routine prophylactic antiepileptics to brain-met patients who have not had a seizure
- Haemorrhagic brain mets: think melanoma, renal cell, choriocarcinoma, thyroid
- If CNS lymphoma is possible, discuss BEFORE giving steroids - they can obscure the diagnosis on biopsy
- Solitary accessible metastasis in controlled systemic disease may be resectable/curatively irradiated - always discuss with neuro-oncology
- Some modern targeted/immunotherapies have meaningful CNS activity - oncology input matters even for brain disease
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.